Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors
- Status
- COMPLETED
- Phase
- N/A
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
- Status
- COMPLETED
- Phase
- PHASE2
Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Study of Etanercept in Dermatomyositis
- Status
- COMPLETED
- Phase
- PHASE1
Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE4
Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3